KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bristol Myers Squibb (BMY) Long-Term Investments (2016 - 2026)

Bristol Myers Squibb has reported Long-Term Investments over the past 17 years, most recently at $366.0 million for Q1 2026.

  • Quarterly Long-Term Investments rose 6.4% to $366.0 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $366.0 million through Mar 2026, up 6.4% year-over-year, with the annual reading at $396.0 million for FY2025, 23.75% up from the prior year.
  • Long-Term Investments was $366.0 million for Q1 2026 at Bristol Myers Squibb, down from $396.0 million in the prior quarter.
  • Over five years, Long-Term Investments peaked at $406.0 million in Q3 2025 and troughed at $320.0 million in Q4 2024.
  • The 4-year median for Long-Term Investments is $360.5 million (2023), against an average of $359.0 million.
  • Year-over-year, Long-Term Investments decreased 12.09% in 2024 and then increased 25.31% in 2025.
  • A 4-year view of Long-Term Investments shows it stood at $364.0 million in 2023, then dropped by 12.09% to $320.0 million in 2024, then rose by 23.75% to $396.0 million in 2025, then fell by 7.58% to $366.0 million in 2026.
  • Per Business Quant, the three most recent readings for BMY's Long-Term Investments are $366.0 million (Q1 2026), $396.0 million (Q4 2025), and $406.0 million (Q3 2025).